Clinical Trial Update: Study of Milnacipran for the Treatment of Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 trial of Milnacipran for the treatment of fibromyalgia has completed, sponsored by Forest Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED